Letter from the Editor: Stewart Parnell’s ride on the ‘Great Writ’ is about to start its 5th year.

Stewart Parnell is the most reviled character from one of food safety’s worst tragedies.

By their convictions and sentencing, Stewart Parnell, 69, and brother Michael Parnell, 64, respectfully still have 15 and 8 years before their prison release dates.

Their jury convictions and trial judge rulings were all upheld by the Appellate Court in 2018.

Nine deaths were associated with the outbreak.

Those nine had families that miss them to this day. Those families see Stewart Parnell as a despicable character whose reckless disregard for life caused the death of their loved ones.

But for now, about to start its fifth year, Stewart Parnell has played the last card he has left. It’s been called the “Great Writ” of habeas corpus. It is a fundamental right in the Constitution that protects against unlawful and indefinite imprisonment. In Latin, it means “show me the body.” Habeas corpus is supposed to safeguard individual freedom against arbitrary executive power.

Stewart Parnell’s Habeas corpus petition was filed on Sept. 6, 2019. After being denied on. Sept. 23, 2022, by the trial judge for the federal District Court, the 11th Circuit took up Parnell’s Habeas petition on appeal.

And the Appellate Court has issued Parnell a “certificate of appealability” on two issues. Those are jury prejudice and ineffective assistance of counsel. With deep experience in federal appeals, Savannah Attorney Amy Lee Copeland has recently filed a 68-page appellate brief for Stewart Parnell and followed it with a few hundred pages of appendix.

The Parnell appeal includes mounds of local, state, and national media stories to illustrate the climate from the outbreak through the trial.  Copeland said about 8,000 were in the jury pool in the Court’s Albany Division at the time of the trial.   

This is a lot to digest, but it all boils the case down.

“The nine deaths did not come into evidence at trial,” Attorney Copeland writes.  “The government agreed not to introduce that evidence.” Two who knew about the deaths entered the jury and into juror deliberations.

It breaks down into whether those nine deaths couldn’t be put aside in a community with the peanut industry too damaged by the Salmonella outbreak blamed entirely on Stewart Parnell’s Peanut Corporation of America. 

Criminal charges were not brought for four years after the outbreak, but .jury selection showed that 60 percent of the prospective jurors knew about the case.

In testimony two years ago, an Albany peanut broker said the Salmonella outbreak at PCA “devastated” the industry. “The sentiment in the local community was ‘under attack by the media,’ especially after reports of death resulting from the salmonella ‘hit the fan,’ ” according to the appellate brief.

Parnell’s trial attorneys did not seek a change of venue for the original jury trial. His defense team members all testified at an evidentiary hearing two years ago. They thought Albany would be the friendliest venue for the PCA trial, but they may have misread the public badly.

The 2014 jury trial was held in Albany, GA, where 60 percent of America’s peanuts are grown within a 150-mile radius. PCA’s peanut processing plant in Blakely, GA, was 65 miles away.

A change of venue is not required if prospective jurors are merely exposed to facts of a case, but only if “inflammatory, prejudicial pretrial publicity “ pervades or saturates the community making a fair trial “virtually impossible.”

Parnell has established “a presumption of jury prejudice,” according to Copeland. “The Sixth Amendment secures criminal defendants the right to trial by an impartial jury,” she said.

And when the deaths were not allowed to be even mentioned at trial, Copeland says jurors were using terms like “fry them” and “hang” and “exact a pound of flesh” as they convicted Parnell on 67 of 68 counts against him.

Many of us remember from our Civil War history that President Lincoln suspended the Writ so certain Rebels could not escape the military’s jurisdiction. The Lincoln suspension ended after four years when the Civil War was over. Parnell’s Writ, however, will go on a bit longer.

(To sign up for a free subscription to Food Safety News, click here.)

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
Vibrating Crib Mattress Eases Opioid Withdrawal for Exposed Infants thumbnail

Vibrating Crib Mattress Eases Opioid Withdrawal for Exposed Infants

Pediatrics > General Pediatrics — "A great need to reduce medication treatment in this vulnerable population," says researcher by Jennifer Henderson, Enterprise & Investigative Writer, MedPage Today May 15, 2023 A crib mattress designed to vibrate gently for tactile sensory stimulation eased neonatal opioid withdrawal syndrome, reducing need for pharmacologic treatment, a randomized clinical trial
Read More
How Much Does Screentime Really Affect Child Development? thumbnail

How Much Does Screentime Really Affect Child Development?

Please enable cookies. Error 1005 Ray ID: 865a7787ee9c8a02 • 2024-03-17 05:08:45 UTC What happened? The owner of this website (www.medscape.com) has banned the autonomous system number (ASN) your IP address is in (47583) from accessing this website. Was this page helpful? Thank you for your feedback! Cloudflare Ray ID: 865a7787ee9c8a02 • Your IP: 185.124.111.116 •
Read More
Bispecific Antibodies in Relapsed/Refractory DLBCL thumbnail

Bispecific Antibodies in Relapsed/Refractory DLBCL

Follow-up data from the EPCORE NHL-1 trial lend further support to the efficacy and safety of single-agent epcoritamab (Epkinly) in the treatment of relapsed/refractory diffuse large B-cell lymphoma (DLBCL), according to a presentation at the American Society of Clinical Oncology (ASCO) annual meeting. MedPage Today brought together three expert leaders in the field: Moderator Ian
Read More
What the SABCS 'Year in Review' Session May Bring in 2023 thumbnail

What the SABCS ‘Year in Review’ Session May Bring in 2023

Meeting Coverage > SABCS Future Focus — Virginia Kaklamani, MD, makes some hopeful predictions by Greg Laub, Director, Video, MedPage Today December 15, 2022 Each year, the San Antonio Breast Cancer Symposium (SABCS) concludes with the always-popular "Year in Review" session. Last week, SABCS co-directors Virginia Kaklamani, MD, of UT Health Sciences Center in San
Read More
Index Of News
Total
0
Share